Skip to main content

Gallium Ga 68 gozetotide Pregnancy and Breastfeeding Warnings

Brand names: Illuccix, Locametz

Gallium Ga 68 gozetotide Pregnancy Warnings

This drug is not indicated for use in female patients.

US FDA pregnancy category: Not assigned.

Risk summary:
No data available on use of this drug in pregnant women to inform a drug-related risk. All radiopharmaceuticals including this drug have the potential to cause fetal harm.

Animal reproduction studies have not been conducted. There are no controlled data in human pregnancy.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Gallium Ga 68 gozetotide Breastfeeding Warnings

This drug is not indicated for use in female patients.

Excreted into human milk: Unknown
Excreted into animal milk: Unknown

Comments:
The effects in the nursing infant or on milk production are unknown.

See references

References for pregnancy information

  1. (2022) "Product Information. Locametz (gozetotide)." Advanced Accelerator Applications
  2. (2023) "Product Information. Locametz (gozetotide)." Advanced Accelerator Applications (UK & Ireland) Ltd

References for breastfeeding information

  1. (2022) "Product Information. Locametz (gozetotide)." Advanced Accelerator Applications
  2. (2023) "Product Information. Locametz (gozetotide)." Advanced Accelerator Applications (UK & Ireland) Ltd

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer